1. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present
    Muhammad Begawan Bestari et al, 2024, Biomolecules CrossRef
  2. A simplified lateral flow immunosensor for the assay of carcinoembryonic antigen in low-resource settings
    Ioanna Tsogka et al, 2024, Analytical Methods CrossRef
  3. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study
    Amy Makler et al, 2023, International Journal of Molecular Sciences CrossRef
  4. Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma
    Benjamin E. Stubbe et al, 2023, Pancreatology CrossRef
  5. Feasibility of 125I brachytherapy combined with arterial infusion chemotherapy in patients with advanced pancreatic cancer
    Shujing Huang et al, 2023, Medicine CrossRef
  6. Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
    Julien Taieb et al, 2023, BMC Cancer CrossRef
  7. Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serological markers: a cohort study of machine learning
    Zhongyu Yuan et al, 2023, Abdominal Radiology CrossRef
  8. Significantly Elevated CA 19-9 after COVID-19 Vaccination and Literature Review of Non-Cancerous Cases with CA 19-9 > 1000 U/mL
    Jakub Ciesielka et al, 2024, Journal of Clinical Medicine CrossRef
  9. Electrochemical immunoplatform to help managing pancreatic cancer
    Víctor Pérez-Ginés et al, 2023, Journal of Electroanalytical Chemistry CrossRef
  10. Biological risk based on preoperative serum CA19‐9 and histological grade predicts prognosis and improves accuracy of classification in patients with pancreatic ductal adenocarcinoma
    Shaofei Chang et al, 2023, Cancer Reports CrossRef
  11. Can combined use of tumor markers in pancreatic cancer be a solution to short- and long-term consequences?: A retrospective study
    Ebru Esen et al, 2023, Medicine CrossRef
  12. Raman scattering-based optical sensing of chronic liver diseases
    Khaled Alkhuder, 2023, Photodiagnosis and Photodynamic Therapy CrossRef
  13. Unlocking the potential of oncology biomarkers: advancements in clinical theranostics
    Ankit Kumar Dubey et al, 2024, Drug Metabolism and Personalized Therapy CrossRef
  14. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma
    Kosta Stosic et al, 2023, Cells CrossRef
  15. Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer
    Xin Gu et al, 2024, Cancers CrossRef